BioSpace News Archive

CURE Pharmaceutical Holding Corp . (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space today announced that its subsidiary Sera Labs has launched a robust national advertising campaign

Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, Chief Executive Officer will participate in the ROTH Virtual Conference on Tuesday March 16, 2021.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its fourth quarter and full year 2020 financial results on Wednesday, March 10, 2021, after the market closes.

Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that it will host a conference call and live audio webcast on March 11, 2021

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today the completion of the Company’s Phase 2b clinical study of Lomecel-B infusion for Aging Frailty subject

Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of CNS disorders, announced today that David Baker, President & Chief Executive Officer of Vallon will present at the virtual H.C. Wainwright Global Life Sciences Conference, which is taking place March 9 and 10, 2021.

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced that the Company will present at the upcoming H.C. Wainwright Global Life Sciences Conference

Fact.MR, a global research & consulting firm, in their latest edition of the report, anticipated that the vertebrobasilar insufficiency treatment market is projected to foresee a steady growth pace.

Endovenous ablation devices are used to treat chronic venous insufficiency with varicose veins. These type of devices are specially designed for minimally invasive procedures.

Keratoconus is considered to be a progressive eye disorder in which the cornea, which is normally round in shape, thins, and starts bulging into a cone-like shape.